MEDICINA
Departamento
French Institute of Health and Medical Research
París, FranciaPublicaciones en colaboración con investigadores/as de French Institute of Health and Medical Research (25)
2021
-
COVID-19 vaccination in patients with multiple myeloma: a consensus of the European Myeloma Network
The Lancet Haematology, Vol. 8, Núm. 12, pp. e934-e946
-
Common gene variants within 3′-untranslated regions as modulators of multiple myeloma risk and survival
International Journal of Cancer, Vol. 148, Núm. 8, pp. 1887-1894
2020
-
Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of EBMT and ISCT (JACIE)
Bone Marrow Transplantation, Vol. 55, Núm. 2, pp. 283-306
-
Clinical features associated with COVID-19 outcome in multiple myeloma: First results from the International Myeloma Society data set
Blood, Vol. 136, Núm. 26, pp. 3033-3040
-
Management of adults and children undergoing chimeric antigen receptor T-cell therapy: Best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)
Haematologica, Vol. 105, Núm. 2, pp. 297-316
2019
-
Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma
Leukemia
-
High subclonal fraction of 17p deletion is associated with poor prognosis in multiple myeloma
Blood, Vol. 133, Núm. 11, pp. 1217-1221
2018
-
Imaging features and safety and efficacy of endovascular stroke treatment: a meta-analysis of individual patient-level data
The Lancet Neurology, Vol. 17, Núm. 10, pp. 895-904
-
Maintenance Treatment and Survival in Patients with Myeloma: A Systematic Review and Network Meta-analysis
JAMA Oncology, Vol. 4, Núm. 10, pp. 1389-1397
2017
-
Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Annals of Oncology, Vol. 28, pp. iv52-iv61
2016
-
Carfilzomib significantly improves the progression-free survival of high-risk patients in multiple myeloma
Blood, Vol. 128, Núm. 9, pp. 1174-1180
-
Homeobox NKX2-3 promotes marginal-zone lymphomagenesis by activating B-cell receptor signalling and shaping lymphocyte dynamics
Nature Communications, Vol. 7
2015
2014
-
Impact of in vivo T-cell depletion on outcome of AML patients in first CR given peripheral blood stem cells and reduced-intensity conditioning allo-SCT from a HLA-identical sibling donor: A report from the Acute Leukemia Working Party of the European group for Blood and Marrow Transplantation
Bone Marrow Transplantation, Vol. 49, Núm. 3, pp. 389-396
2011
-
Mobilization of plasma cells in healthy individuals treated with granulocyte colony-stimulating factor for haematopoietic stem cell collection
Immunology, Vol. 132, Núm. 2, pp. 266-272
2010
-
Circulating human b and plasma cells. age-associated changes in counts and detailed characterization of circulating normal CD138- and CD138 plasma cells
Haematologica, Vol. 95, Núm. 6, pp. 1016-1020
-
Human peripheral blood B-Cell compartments: A crossroad in B-cell traffic
Cytometry Part B - Clinical Cytometry, Vol. 78, Núm. SUPPL. 1
2003
2002
-
P8-deficient fibroblasts grow more rapidly and are more resistant to adriamycin-induced apoptosis
Oncogene, Vol. 21, Núm. 11, pp. 1685-1694